Back to search
Recurrent Childhood Neuroblastoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Childhood Neuroblastoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Childhood Neuroblastoma trials you may qualify forThe phase I portion of this study is designed for children or adolescents and young adults (AYA) with a diagnosis of a solid tumor that has recurred (come back…
The purpose of this study is to find out whether avutometinib is a safe treatment for advanced or recurrent solid tumor cancers in children and young adults. Re…
A pilot pharmacokinetic trial to determine the safety and efficacy of a flavored, orally administered irinotecan VAL-413 (Orotecan®) given with temozolomide for…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…
This phase I trial investigates the side effects and determines the best dose of an immune cell therapy called GD2CART, as well as how well it works in treating…